Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
• To evaluate the efficacy of GDC-0810 compared with fulvestrant in the intent to treat (ITT) population as measured by progression free survival (PFS) • To evaluate the efficacy of GDC-0810 compared with fulvestrant in the estrogen receptor 1 (ESR1) mutant population as measured by PFS
Inclusion criteria
- Advanced or Metastatic ER+/HER2- Breast Cancer